Rise in the chronic diseases and increase in the air pollution & air quality are some of the significant reasons to propel the growth of the acute respiratory distress syndrome market during the forecast years.
Market Size – USD 583.8 Million in 2018, Market Growth - CAGR of 6.0% for the year 2026, Market trends – Increasing lung injuries due to car accidents with various chronic diseases such as pulmonary or systemic infection, neurological conditions, among others.
According to the analysis of Reports and Data, the global acute respiratory distress syndrome market was valued at USD 583.8 Million in 2018 and is expected to reach USD 934.8 Million by the year 2026, at a CAGR of 6.0%. Acute respiratory distress syndrome (ARDS) is a type of respiratory failure, which is a form of lung inflammation. Due to which there is a problem with the proper delivery of the oxygen to the different body organs, which at the end impact the appropriate functioning of the parts. Various causes are included with the ARDS, such as sepsis, trauma, pneumonia, and others. The primary treatment for the ARDS involves mechanical ventilation, which is delivered through a rigid tube that enters the oral cavity and is secured in the airway.
According to a survey done by the World Health Organization (WHO), it is seen that more than 3 million people are effects due to acute respiratory distress syndrome. It can affect people of all ages. The main reason for the ARDS is air pollution, which is caused due to the emission by the vehicles. The harmful gases emitted are inhaled by the people thus leading to several problems.
Different strategic initiatives have been undertaken by the various players in the ARDS industry. For instance, on December 2018, Windtree Therapeutics, Inc. a biopharmaceutical company merged with CVie Therapeutics and launched AEROSURF, a combination drug/device product which is used to treat respiratory distress syndrome.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2089
The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers. The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors. It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships.
Top companies profiled in the report include:
Faron Pharmaceuticals, BioMarck Pharmaceuticals, GE Healthcare, Hamilton Medical AG, Smiths Medical, Athersys, GlaxoSmithKline, Altor Bioscience, and Mondobiotech.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2089
The report also covers SWOT analysis and Porter’s Five Forces analysis along with feasibility analysis and investment return analysis. Key statistical data has been organized in tables, charts, diagrams, figures, and other pictorial representations. The report also offers strategic recommendations to established players as well as details on entry barriers for new entrants.
The report covers the Acute Respiratory Distress Syndrome (ARDS) market on a global scale along with market breakdown into product types, applications, technology, end-user, and key regions.
Device Type (Revenue in USD Million; Volume in Tons, 2017–2027)
Injury Type (Revenue in USD Million; Volume in Tons, 2017–2027)
Severity (Revenue in USD Million; Volume in Tons, 2017–2027)
Treatment (Revenue in USD Million; Volume in Tons, 2017–2027)
Sales Channel (Revenue in USD Million; Volume in Tons, 2017–2027)
End User (Revenue in USD Million; Volume in Tons, 2017–2027)
Regional analysis covers:
• North America (U.S.A., Canada, Mexico)
• Europe(U.K., Italy, Germany, France, Rest of EU)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
The study also analyses the market share, growth forecast and rate, current and future trends, market drivers and restraints, opportunities and challenges, risks, and threats. The report also covers a comprehensive analysis of the changing market dynamics and offers a futuristic outlook of industry.
To know more about the report @ https://www.reportsanddata.com/report-detail/acute-respiratory-distress-syndrome-ards-market
Key Features of the Global Acute Respiratory Distress Syndrome (ARDS) Market Report:
· Comprehensive analysis of the key players operating in the market along with their SWOT analysis, their business profiles, business overview, market share, global position, and market value
· Identification and analysis of significant trends and factors driving revenue growth of the market
· Analysis of the competitive landscape along with strategic mergers, expansions, agreements, partnerships, joint ventures, acquisitions, and product launches
· Assessment of each market segment along with their growth trends and market revenue contribution
· Study of the key regions to pinpoint growth potential and study opportunities, threats, limitations, and risks
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2089
Thank you for reading our report. Please get in touch with us to know more about the report and its customization. Our team will ensure the report is tailored according to your requirements.
Explore our related report from different Publications: